STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

PRAH PRA HEALTH SCIENCES StockScouter® Report

6

StockScouter® Score

PRA HEALTH SCIENCES, a mid cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • The ratio of PRAH’s forward price-to-earnings multiple to its estimated growth rate is below the average of comparably-sized companies in the StockScouter universe. Positive

 

Concerns

  • The multi-period measure of relative price change and consistency is below average. Negative/Neutral
  • Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a large company like PRAH

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 80% done.
Low
High

Core Model Grades

B
C
C
D

Previous Ratings

7
7
9